Ana M. Molina, M.D. Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York, shares information that she feels the public should know about kidney cancer.
Ana M. Molina, MD
Advertisement
Articles by Ana M. Molina, MD
Ana M. Molina, M.D. Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York, talks about her presentation at 2011 ASCO Genitourinary conference.
Ana M. Molina, M.D. Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York Talks About Her Involvement in New Clinical Trials
Ana M. Molina, MD, Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York Discusses Recent Pazopanib Clinical Trials.
Ana M. Molina, M.D. Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York Explains Advancements in Kidney Cancer Over the Past Several Years
Ana M. Molina, MD, Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York Gives Advice for Newly Diagnosed Kidney Cancer Patients
Ana M. Molina, M.D. Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York Discusses what Separates MSKCC From Other Top Cancer Centers Worldwide
Ana M. Molina, M.D. Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York Talks About how Patient Treatment has Changed Over the Past Few Years
Ana M. Molina, M.D. Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York Talks About Pazopanib, Sunitinib and Other Recent Clinical Trials
Advertisement
Latest Updated Articles
Pazopanib, Sunitinib and Other Recent Clinical TrialsPublished: March 14th 2011 | Updated:
Patient Treatment Changes Over the Past Few YearsPublished: March 14th 2011 | Updated:
What Separates MSKCC From Cancer Centers WorldwidePublished: March 14th 2011 | Updated:
Dr. Molina on Her Recent Presentation at ASCO GU 2011Published: March 14th 2011 | Updated:
Dr. Molina Talks About Her Involvement in Clinical TrialsPublished: March 14th 2011 | Updated:
Dr. Molina on Information for the Public on Kidney CancerPublished: March 14th 2011 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
4
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
5